Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants

NCT03460405 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety Issues
Immunogenicity

Interventions

BIOLOGICAL: Vi-DT Vaccine
BIOLOGICAL: Vi Polysaccharide Vaccine
BIOLOGICAL: IPV Vaccine

Sponsor

PT Bio Farma